News
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE) NRG/GU010 - ...
finally headed toward clinical trials near the end of 1999. Folkman was expected to cure cancer—it said so in The New York Times. Now all he needed was for the drugs to work in people as ...
Cancer clinical trials represent a critical mechanism to advance the fields of hematology and oncology. Every US Food and Drug Administration (FDA)-approved cancer treatment has made its way through ...
Only about 3% of women with breast cancer take part in clinical trials, according to Y-ME, the national breast cancer organization. This low level of clinical research participation may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results